R
Roy M. Robins-Browne
Researcher at University of Melbourne
Publications - 316
Citations - 20744
Roy M. Robins-Browne is an academic researcher from University of Melbourne. The author has contributed to research in topics: Virulence & Yersinia enterocolitica. The author has an hindex of 74, co-authored 309 publications receiving 19093 citations. Previous affiliations of Roy M. Robins-Browne include University of Guelph & Royal Children's Hospital.
Papers
More filters
Journal ArticleDOI
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.
Karen L. Kotloff,James P. Nataro,William C. Blackwelder,Dilruba Nasrin,Tamer H. Farag,Sandra Panchalingam,Yukun Wu,Samba O. Sow,Dipika Sur,Robert F. Breiman,Abu Syed Golam Faruque,Anita K. M. Zaidi,Debasish Saha,Pedro L. Alonso,Boubou Tamboura,Doh Sanogo,Uma Onwuchekwa,Byomkesh Manna,Thandavarayan Ramamurthy,Suman Kanungo,John B. Ochieng,Richard Omore,Joseph Oundo,Anowar Hossain,Sumon Kumar Das,Shahnawaz Ahmed,Shahida Qureshi,Farheen Quadri,Richard A. Adegbola,Richard A. Adegbola,Martin Antonio,M. Jahangir Hossain,Adebayo Akinsola,Inacio Mandomando,Tacilta Nhampossa,Sozinho Acácio,Kousick Biswas,Ciara E. O’Reilly,Eric D. Mintz,Lynette Y. Berkeley,Lynette Y. Berkeley,Khitam Muhsen,Halvor Sommerfelt,Halvor Sommerfelt,Roy M. Robins-Browne,Myron M. Levine +45 more
TL;DR: Interventions targeting five pathogens can substantially reduce the burden of moderate-to-severe diarrhoea and suggest new methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes.
Journal ArticleDOI
Probiotic use in clinical practice: what are the risks?
TL;DR: Although probiotics have an excellent overall safety record, they should be used with caution in certain patient groups-particularly neonates born prematurely or with immune deficiency, and further investigation is needed in these areas.
Journal ArticleDOI
Emergence of multiply resistant pneumococci.
Michael R. Jacobs,Hendrik J. Koornhof,Roy M. Robins-Browne,C M Stevenson,Z A Vermaak,I Freiman,G B Miller,M A Witcomb,M Isaäcson,J. I. Ward,R Austrian +10 more
TL;DR: Carriers of Types 6A and 19A penicillin-resistant pneumococci, resistant to antibiotic concentrations ranging between 0.12 and 4 microgram per milliliter were found in 29 of 543 pediatric patients and 2 of 434 hospital staff members in Johannesburg in July, 1977.
Journal ArticleDOI
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells.
James P. Nataro,James B. Kaper,Roy M. Robins-Browne,Valeria Prado,Pablo Vial,Myron M. Levine +5 more
TL;DR: A total of 516 Escherichia coli strains randomly isolated from coprocultures of 154 Chilean children with diarrhea and 66 controls were examined with DNA probes and tested for adherence to HEp-2 cells, and the aggregative pattern appears to signify a new, distinct class of diarrheagenic E. coli (enteroadherent-aggregative E coli).
Journal ArticleDOI
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Benjamin P Howden,Christopher R.E. McEvoy,David L. Allen,Kyra Y. L. Chua,Kyra Y. L. Chua,Wei Gao,Paul Harrison,Jan M. Bell,Geoffrey W. Coombs,Vicki Bennett-Wood,Jessica L. Porter,Roy M. Robins-Browne,John K. Davies,Torsten Seemann,Timothy P. Stinear,Timothy P. Stinear +15 more
TL;DR: The role played by walKR to increase drug resistance, control metabolism and alter the virulence potential of this pathogen is demonstrated and demonstrates the dramatic impacts of single mutations that arise during persistent S. aureus infections.